The current status of invasive pneumococcal disease in Poland

被引:32
作者
Skoczynska, Anna [1 ]
Sadowy, Ewa [2 ]
Bojarska, Katarzyna
Strzelecki, Janusz
Kuch, Alicja [1 ]
Golebiewska, Agnieszka [1 ]
Wasko, Izabela [1 ]
Forys, Malgorzata [1 ]
van der Linden, Mark [3 ]
Hryniewicz, Waleria [1 ]
机构
[1] Natl Reference Ctr Bacterial Meningitis, Natl Med Inst, Dept Epidemiol & Clin Microbiol, PL-00725 Warsaw, Poland
[2] Natl Med Inst, Dept Mol Microbiol, Warsaw, Poland
[3] Univ Hosp, Natl Reference Ctr Streptococci, Aachen, Germany
关键词
Invasive pneumococcal disease; Streptococcus pneumoniae; Serotype; STREPTOCOCCUS-PNEUMONIAE SEROTYPES; CONJUGATE VACCINE PCV7; ANTIBIOTIC-RESISTANCE; CHILDREN; DECLINE; SUSCEPTIBILITY; EPIDEMIOLOGY; MENINGITIS; IMPACT; ADULTS;
D O I
10.1016/j.vaccine.2010.09.100
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objectives of this study were to assess the incidence of invasive pneumococcal disease (IPD) in Poland (2006-2009), where mass vaccination had not been implemented, and to determine the serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates. The IPD incidence rates were highest among children under 2 years of age (3.39/100,000 in 2009) and children 2-5 years old (2.44/100,000). The most common serotypes were 14, 3, 1, 4, 19F, 23F, 6B, and 12F (61.7% of all isolates). In children aged less than 5 years, isolates of serotypes 14, 68, and 19F were most prevalent (52.7% of the IPD cases). The PCV7, PCV10, and PCVI3 covered 43.3%, 54.8%, and 68.8% of all IPD cases, and 68.7%, 76.3%, and 86.3% of cases involving children under 5 years of age. Penicillin resistance was found in 21.3% of the isolates responsible for meningitis and in 1.2% of isolates responsible for other invasive infections. Introduction of antipneumococcal conjugated vaccines into the national immunisation programme would likely lead to a significant reduction of IPD-associated morbidity among Polish children in particular, as well as in the population as a whole, especially in cases involving pneumococci with a decreased susceptibility to antibiotics. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2199 / 2205
页数:7
相关论文
共 39 条
  • [1] STREPTOCOCCUS-PNEUMONIAE - VIRULENCE FACTORS, PATHOGENESIS, AND VACCINES
    ALONSODEVELASCO, E
    VERHEUL, AFM
    VERHOEF, J
    SNIPPE, H
    [J]. MICROBIOLOGICAL REVIEWS, 1995, 59 (04) : 591 - &
  • [2] [Anonymous], 2000, MMWR Recomm Rep, V49, P1
  • [3] Resistance among Streptococcus pneumoniae:: Implications for drug selection
    Appelbaum, PC
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) : 1613 - 1620
  • [4] Invasive pneumococcal disease among children in a health district of Barcelona:: early impact of pneumococcal conjugate vaccine
    Calbo, E.
    Diaz, A.
    Canadell, E.
    Fabrega, J.
    Uriz, S.
    Xercavins, M.
    Morera, M. A.
    Cuchi, E.
    Rodriguez-Carballeira, M.
    Garau, J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (09) : 867 - 872
  • [5] Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan
    Chiba, N.
    Morozumi, M.
    Sunaoshi, K.
    Takahashi, S.
    Takano, M.
    Komori, T.
    Sunakawa, K.
    Ubukata, K.
    [J]. EPIDEMIOLOGY AND INFECTION, 2010, 138 (01) : 61 - 68
  • [6] Streptococcus pneumoniae serotype 19A in children, South Korea
    Choi, Eun Hwa
    Kim, So Hee
    Eun, Byung Wook
    Kim, Sun Jung
    Kim, Nam Hee
    Lee, Jina
    Lee, Hoan Jong
    [J]. EMERGING INFECTIOUS DISEASES, 2008, 14 (02) : 275 - 281
  • [7] *CLIN LAB STAND I, 2010, M100S20 CLIN LAB STA
  • [8] Impact of conjugate pneumococcal vaccines on antibiotic resistance
    Dagan, Ron
    Klugman, Keith P.
    [J]. LANCET INFECTIOUS DISEASES, 2008, 8 (12) : 785 - 795
  • [9] Dinleyici EC, 2009, EXPERT REV VACCINES, V8, P977, DOI [10.1586/erv.09.68, 10.1586/ERV.09.68]
  • [10] Efficacy of a pneumococcal conjugate vaccine against acute otitis media
    Eskola, J
    Kilpi, T
    Palmu, A
    Jokinen, J
    Haapakoski, J
    Herva, E
    Takala, A
    Käyhty, H
    Karma, P
    Kohberger, R
    Siber, G
    Mäkela, PH
    Lockhart, S
    Ecrola, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (06) : 403 - 409